CD79A and myeloid sarcoma: Specifically, IgG, IgA and IgM antibodies targeting the dsRNA synthetic analog Poly(I:C) were measured in plasma samples from MS patients (n = 70) and healthy controls (n = 26), as well as in CSF samples from a subset of MS patients (n = 22).